Der Pharmakonzern Roche plant, im grossen Stil in den Standort Basel zu investieren. In den kommenden zehn Jahren sollen auf dem bestehenden Areal insgesamt 3 Milliarden Franken in den Bau eines ...

Roche’s R&D is moving on up. The pharma giant has opened two new high-rises in Basel, Switzerland, according to a Sept. 10 release.The facility is named the Pharma Research and Early Development ...

Roche announced the opening of its new Pharma Research and Early Development (pRED) Centre at its global headquarters in Basel, Switzerland. Equipped with cutting-edge technologies and housing around ...

The canton of Basel City has shown Swiss pharmaceutical giant Roche that it is confident in the company's environmental record. In the first accord of its kind in the canton, the authorities are ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the opening of its new Pharma Research and Early Development (pRED) Center at its global headquarters in Basel, Switzerland. Equipped with ...

Basel, Switzerland-based Roche currently maintains 13 manufacturing and 15 R&D sites in the U.S. across its pharmaceutical and diagnostics divisions. These sites employ more than 25,000.

GENEVA — Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company ...

Basel, 10 September 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the opening of its new Pharma Research and Early Development (pRED) Center at its global headquarters in Basel ...